Author
Listed:
- Florence P. A. M. Hunsel
(Netherlands Pharmacovigilance Centre Lareb)
- Djurre Kooi
(Netherlands Pharmacovigilance Centre Lareb
University of Groningen)
- Sonja Koppel
(Netherlands Pharmacovigilance Centre Lareb)
- Burt H. Kroes
(Dutch Medicines Evaluation Board)
- Herman J. Woerdenbag
(Netherlands Pharmacovigilance Centre Lareb)
Abstract
Introduction The inclusion of herbal medicinal products and herbal supplements in pharmacovigilance systems is important because a systematic approach of collecting and analyzing adverse drug reactions related to these products will help practitioners, patients, and regulators to gain more knowledge and prevent harm. Objective We aimed to categorize the adverse drug reaction reports on herbal medicinal products and herbal supplements submitted to the Pharmacovigilance Centre Lareb between 1991 and February 2021 on the basis of their regulatory status, herbs included, and adverse drug reactions involved. Methods We categorized products on the basis of their registration status and herbal ingredients. The products were then categorized according to the Herbal Anatomical Therapeutic Chemical Classification System. We used descriptive statistics in Microsoft Excel 2019. Pivot tables were used for the analysis and presentation of the data. Results Until February 2021, a total of 789 reports of herbal medicinal products and herbal supplements were received by Lareb. In these reports, a total of 823 herbal products were labeled as suspect. These products caused a total of 1727 adverse drug reactions. Of the 823 products, 229 were registered as a medicine, and 594 were on the market as a herbal supplement. Of the 823 herbal products, 522 reports concerned single-herb products, 256 reports concerned combination products, 27 reports concerned vitamin products containing herbal ingredients, and 18 reports concerned product issues. Approximately 15% of reports concerned serious adverse drug reactions, and adulterated products harbored a high risk of causing serious adverse drug reactions. Conclusions Analysis of the herbal medicinal products and herbal supplements in the Dutch pharmacovigilance database revealed a variety of suspected herbal ingredients. The reports provide insight into the variety of herbal products used in the Netherlands and the adverse reactions associated with their use. Pharmacovigilance of herbal products is essential to ensure their safe use.
Suggested Citation
Florence P. A. M. Hunsel & Djurre Kooi & Sonja Koppel & Burt H. Kroes & Herman J. Woerdenbag, 2022.
"Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb,"
Drug Safety, Springer, vol. 45(6), pages 651-661, June.
Handle:
RePEc:spr:drugsa:v:45:y:2022:i:6:d:10.1007_s40264-022-01180-5
DOI: 10.1007/s40264-022-01180-5
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Vyacheslav Dolganyuk & Stanislav Sukhikh & Olga Kalashnikova & Svetlana Ivanova & Egor Kashirskikh & Alexander Prosekov & Philippe Michaud & Olga Babich, 2023.
"Food Proteins: Potential Resources,"
Sustainability, MDPI, vol. 15(7), pages 1-20, March.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:45:y:2022:i:6:d:10.1007_s40264-022-01180-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.